Basic Information
LncRNA/CircRNA Name | UCA1 |
Synonyms | UCA1, CUDR, LINC00178, NCRNA00178, UCAT1, onco-lncRNA-36 |
Region | GRCh38_19:15828206-15836326 |
Ensemble | ENSG00000214049 |
Refseq | NR_015379 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | Cisplatin and temozolomide | |
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | glioma |
ICD-0-3 | NA |
Methods | qRT-PCR , Western blot etc. |
Sample | glioma tissues and adjacent normal brain tissues ,human astrocytes and glioma cell lines( SHG44,U251, U87 and SHG139) |
Expression Pattern | up-regulated |
Function Description | UCA1 was found to be highly up-regulated in glioma cells, and knock-down of UCA1 inhibited cell growth, invasion and migration, and also induced apoptosis in glioma cells.Overexpression of UCA1 promoted cell proliferation, cell invasion and migration in glioma cells.Knock-down of UCA1 suppressed the activity of Wnt/?-catenin signaling, and treatment with lithium chloride restored the inhibitory effect of UCA1 knock-down on cell invasion and migration.More importantly, the aberrant expression of UCA1 was associated with chemo-resistance to cisplatin and temozolomide in glioma cells via interacting with Wnt/?-catenin signaling.Overexpression of UCA1 promoted the in vivo tumor growth of U87 cells in the nude mice. Clinically, UCA1 was found to be up-regulated in glioma tissues and higher expression level of UCA1 was correlated with poor survival in patients with glioma. |
Pubmed ID | 31596734 |
Year | 2019 |
Title | The Long Non-Coding RNA, Urothelial Carcinoma Associated 1, Promotes Cell Growth, Invasion, Migration, and Chemo-Resistance in Glioma Through Wnt/?-catenin Signaling Pathway |
External Links
Links for UCA1 | GenBank HGNC NONCODE |
Links for glioma | OMIM COSMIC |